Literature DB >> 11788788

Nitric oxide inhibits endothelial IL-1[beta]-induced ICAM-1 gene expression at the transcriptional level decreasing Sp1 and AP-1 activity.

D Berendji-Grün1, V Kolb-Bachofen, K D Kröncke.   

Abstract

BACKGROUND: Nitric oxide (NO) has frequently been shown to inhibit leukocyte adherence to activated endothelium thus displaying anti-adhesive and immunosuppressive activities. A molecular mechanism contributing to this effect is described.
MATERIALS AND METHODS: Primary murine aortic endothelial cells were activated with interleukin (IL)-1beta to express intercellular adhesion molecule-1 (ICAM-1) mRNA in the presence or absence of the physiological spontaneous NO-donor S-nitrosocysteine. Subsequently, semiquantitative RT-PCR and gel shift assays with nuclear extracts were performed to analyse the effects of NO on ICAM-1 mRNA expression and on the activity of transcription factors involved in ICAM-1 transcription. In addition, luciferase reporter gene activity of cytokine-activated cells transiently transfected with an ICAM-1 promoter-luciferase construct and cultured in the presence of the slow-releasing NO-donor DETA/NO was determined.
RESULTS: NO at subtoxic concentrations decreases IL-1beta-induced endothelial ICAM-1 mRNA expression. This inhibition occurs at the transcriptional level, as NO affects IL-1b-induced ICAM-1 promoter activity in transiently transfected cells. Using gel-shift assays and double-stranded oligonucleotide consensus sequences of the known transcription factor binding sites of the ICAM-1 promoter, Sp1 and AP-1 were identified as transcriptional activators of IL-1beta-driven ICAM-1 expression. The DNA binding of both of these transcription factors to specific binding sites of the ICAM-1 promoter was decreased in MAEC exposed to NO.
CONCLUSIONS: Our studies indicate that the anti-adhesive effect of NO concentrations equivalent to high-output NO synthesis is mediated, at least in part, by inhibition of ICAM-1 expression via a concerted action of NO on the redox-sensitive transcriptional activators Sp1 and AP-1. This molecular mechanism may contribute to the anti-inflammatory actions of NO synthesized by the inducible NO synthase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11788788      PMCID: PMC1950001     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  16 in total

Review 1.  Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities.

Authors:  Young-Myeong Kim; Hyun-Ock Pae; Jeong Euy Park; Yong Chul Lee; Je Moon Woo; Nam-Ho Kim; Yoon Kyung Choi; Bok-Soo Lee; So Ri Kim; Hun-Taeg Chung
Journal:  Antioxid Redox Signal       Date:  2010-10-26       Impact factor: 8.401

2.  ICAM-1-activated Src and eNOS signaling increase endothelial cell surface PECAM-1 adhesivity and neutrophil transmigration.

Authors:  Guoquan Liu; Aaron T Place; Zhenlong Chen; Viktor M Brovkovych; Stephen M Vogel; William A Muller; Randal A Skidgel; Asrar B Malik; Richard D Minshall
Journal:  Blood       Date:  2012-07-17       Impact factor: 22.113

Review 3.  Role of interferon alpha in endothelial dysfunction: insights into endothelial nitric oxide synthase-related mechanisms.

Authors:  Joy N Jones Buie; Jim C Oates
Journal:  Am J Med Sci       Date:  2014-08       Impact factor: 2.378

4.  A Pilot Study to Determine if Vitamin D Repletion Improves Endothelial Function in Lupus Patients.

Authors:  Diane L Kamen; Jim C Oates
Journal:  Am J Med Sci       Date:  2015-10       Impact factor: 2.378

5.  Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology.

Authors:  Susan A Austin; Anantha V Santhanam; David J Hinton; Doo-Sup Choi; Zvonimir S Katusic
Journal:  J Neurochem       Date:  2013-06-27       Impact factor: 5.372

6.  Partial loss of endothelial nitric oxide leads to increased cerebrovascular beta amyloid.

Authors:  Susan A Austin; Zvonimir S Katusic
Journal:  J Cereb Blood Flow Metab       Date:  2019-01-07       Impact factor: 6.200

7.  Tannic acid down-regulates the angiotensin type 1 receptor through a MAPK-dependent mechanism.

Authors:  Rekha Yesudas; Upendra Gumaste; Russell Snyder; Thomas Thekkumkara
Journal:  Mol Endocrinol       Date:  2012-02-09

8.  Pathogenic role of NF-kappaB activation in tubulointerstitial inflammatory lesions in human lupus nephritis.

Authors:  Ling Zheng; Raja Sinniah; Stephen I-Hong Hsu
Journal:  J Histochem Cytochem       Date:  2008-02-18       Impact factor: 2.479

9.  Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo.

Authors:  Serge Marbacher; Volker Neuschmelting; Thilo Graupner; Stephan M Jakob; Javier Fandino
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

10.  CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction.

Authors:  Balachandar Venkatesan; Anthony J Valente; Nitin A Das; Andrea J Carpenter; Tadashi Yoshida; Jean-Luc Delafontaine; Ulrich Siebenlist; Bysani Chandrasekar
Journal:  Cell Signal       Date:  2012-10-17       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.